A phase I trial combining decitabine/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcoma

Decitabine facilitates immune recognition of sarcoma cells by upregulating CT antigens, MHC molecules, and ICAM-1

(2014) Deepa Kolaseri Krishnadas et al.   TUMOR BIOLOGY

Epigenetic Potentiation of NY-ESO-1 Vaccine Therapy in Human Ovarian Cancer

(2014) K. Odunsi et al.   Cancer Immunology Research

CD137 as a Biomarker for Tumor-Reactive T Cells: Finding Gold in the Desert

(2013) Y. Zhu et al.   CLINICAL CANCER RESEARCH

Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients

(2012) P. Sabbatini et al.   CLINICAL CANCER RESEARCH

Complete Remission Following Decitabine/Dendritic Cell Vaccine for Relapsed Neuroblastoma

(2012) D. K. Krishnadas et al.   PEDIATRICS

MAGE-A1, MAGE-A3, and NY-ESO-1 can be upregulated on neuroblastoma cells to facilitate cytotoxic T lymphocyte-mediated tumor cell killing

(2011) Lei Bao et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma

(2010) A. P. Rapoport et al.   BLOOD

Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia

(2010) O. Goodyear et al.   BLOOD

Regulation of cancer germline antigen gene expression: implications for cancer immunotherapy

(2010) Stacey N Akers et al.   Future Oncology

GM-CSF–dependent, CD103+dermal dendritic cells play a critical role in Th effector cell differentiation after subcutaneous immunization

(2010) Irah L. King et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Phase I study of decitabine with doxorubicin and cyclophosphamide in children with neuroblastoma and other solid tumors: A children's oncology group study

(2010) Rani E. George et al.   PEDIATRIC BLOOD & CANCER

Rapid Immune Recovery and Graft-versus-Host Disease-like Engraftment Syndrome following Adoptive Transfer of Costimulated Autologous T Cells

(2009) A. P. Rapoport et al.   CLINICAL CANCER RESEARCH

Timed Sequential Treatment With Cyclophosphamide, Doxorubicin, and an Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor–Secreting Breast Tumor Vaccine: A Chemotherapy Dose-Ranging Factorial Study of Safety and Immune Activation

(2009) Leisha A. Emens et al.   JOURNAL OF CLINICAL ONCOLOGY

Treatment of ovarian cancer cell lines with 5-aza-2′-deoxycytidine upregulates the expression of cancer-testis antigens and class I major histocompatibility complex-encoded molecules

(2008) Sara J. Adair et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Membrane-associated phospholipase A1 beta (LIPI) Is an Ewing tumour-associated cancer/testis antigen

(2008) Juergen L. Foell et al.   PEDIATRIC BLOOD & CANCER